Present status of accelerator-based BNCT: Focus on developments in Argentina

D Cartelli1, M E Capoulat1, J Bergueiro2

  • 1Gerencia de Investigación y Aplicaciones, CNEA, Av. Gral Paz 1499, San Martín, B1650KNA Buenos Aires, Argentina; Escuela de Ciencia y Tecnología, UNSAM, M. de Irigoyen 3100, 1650 San Martín, Argentina; CONICET, Av. Rivadavia 1917, C1033AAJ Buenos Aires, Argentina.

Summary

Accelerator-based Boron Neutron Capture Therapy (AB-BNCT) is advancing globally. This work details the current worldwide status and highlights recent accelerator technology progress in Argentina.

Related Concept Videos

Nuclear Transmutation03:20

Nuclear Transmutation

Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed...
21.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K